Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Month Year
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Apr 30, 2019-- Academic, military and healthcare leaders have come together to conduct a scientifically rigorous clinical trial of a blood test in development for the brain-- Research could lead to the first point-of-care blood test of its kind to help evaluate concussions within minutes- Apr 29, 2019- Research found Abbott's High-Sensitive Troponin-I blood test may identify adults at risk of having a cardiac event, independent of other heart disease risk factors- Abbott's core laboratory diagnostic test is the first troponin blood test with CE Mark that can more accurately predict risk of developing heart disease, when added to other heart disease risk assessments, than using other assessments alone
- Apr 17, 2019- Sales and EPS growth exceed guidance; projects strong full-year outlook- Long-term growth drivers - including FreeStyle Libre, MitraClip and Alinity - achieved strong double-digit growth- Reported sales growth of 2.0 percent; organic sales growth of 7.1 percent, above previous guidance- GAAP diluted EPS from continuing operations of $0.38; adjusted diluted EPS from continuing operations of $0.63, above previous guidance range
- Apr 11, 2019Funding, rapid diagnostics to address emerging threats of cholera, malaria and other diseases, meet key relief needs in Southeast Africa
- Mar 19, 2019- Alinity m will allow labs to meet the growing demand for infectious disease testing by offering increased efficiency and market-leading speed and accuracy- This new technology presents one of the most significant advancements seen in the molecular diagnostics field in decades
- Mar 17, 2019- New MOMENTUM 3 data show the best outcomes seen in a randomized controlled clinical trial for left ventricular assist device (LVAD) therapy- The late-breaking results were presented at the American College of Cardiology's 68th annual Scientific Session and simultaneously published in The New England Journal of Medicine
- Mar 17, 2019- New data presented and simultaneously published in the Journal of the American College of Cardiology show treatment with MitraClip resulted in significant and sustained long-term quality-of-life improvements compared to medical therapy- Data from a sub-analysis of imaging data provides further clarity regarding which patients benefit most from treatment with MitraClip- On Thursday, MitraClip received FDA approval for new, expanded indication to treat heart failure patients with secondary mitral regurgitation
- Mar 14, 2019- The world's first minimally invasive mitral valve repair device now approved to help difficult-to-treat heart failure patients with clinically significant secondary mitral regurgitation- Approval is based on groundbreaking pivotal data from the COAPT™ Trial- New indication significantly expands number of people with mitral regurgitation that can be treated with the MitraClip device
- Mar 6, 2019- Five late-breaking data presentations at ACC 2019 showcase the breadth and depth of Abbott's cardiovascular portfolio- New late-breaking data highlight outcomes for key Abbott cardiovascular technologies: MitraClip, HeartMate 3, CardioMEMS and XIENCE
- Mar 5, 2019Regional Medical Laboratory, Inc., which is part of the Ascension network, partners with Abbott, the global health leader, to advance lab capabilities and help improve health outcomes
- Feb 21, 2019- Data presented at ATTD confirms previous analyses that higher rates of scanning with the FreeStyle Libre system are strongly associated with improved glucose control- Prolonged hypoglycemia reduced by up to 56 percent if users scan a second time within an hour of low glucose readings- Trend arrow readings before meals can help identify glucose levels that can potentially be used to adjust treatment and address after meal hyperglycemia
- Feb 20, 2019Collaboration will enable insulin data to be shared between Novo Nordisk connected insulin pens and digital health tools compatible(i) with FreeStyle Libre portfolio of products
- Feb 20, 2019- New point-of-care rapid test identifies and helps make effective care more accessible for millions of people living with hepatitis B, in support of World Health Organization (WHO) hepatitis targets- Life-changing test has obtained CE Mark and is now available in Europe, Africa, Asia, Latin America, and other countries that recognize CE Mark
- Jan 23, 2019- Full-year 2018 sales growth of 11.6 percent; organic sales growth of 7.3 percent- Issues financial outlook for 2019, reflecting double-digit EPS growth and 6.5 to 7.5 percent organic sales growth
- Jan 21, 2019With approval of the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™, Abbott is helping more physicians integrate ablation with 3D mapping to advance the treatment of people with atrial fibrillation
-
Jan 19, 2019- Data from two recent studies presented at NANS 2019 demonstrate key benefits of BurstDR™ stimulation- Microdosing BurstDR stimulation at lowest effective energy allows patients to manage their pain without the burden of recharging their devices- Additional data further showed switching from other types of SCS therapies to Abbott’s BurstDR stimulation significantly reduced pain and the need for opioid medication
- Jan 17, 2019LONG-TERM AGREEMENT BETWEEN JAPANESE RED CROSS SOCIETY AND ABBOTT BRINGS TOGETHER TWO GLOBAL LEADERS IN BLOOD AND PLASMA SCREENING, HELPING ENSURE A SAFE AND EFFICIENT BLOOD SUPPLY ACROSS JAPAN
- Jan 16, 2019Acquisition to further bolster Abbott's leading position in therapies for mitral valve disease, the most common type of heart valve ailment
- Jan 14, 2019- First and only minimally invasive, transcatheter treatment specifically approved for premature babies with a patent ductus, a life-threatening opening in their heart- Nearly 12,000 very low birth weight babies are born in the U.S. each year with a persistent opening in their heart that requires medical intervention[1,2,3]- Life-saving technology provides new and optimally-sized treatment option to address critical need for the tiniest newborns, including premature infants weighing as little as two pounds
- Jan 11, 2019- Abbott to supply rapid diagnostic tests critical for malaria detection and surveillance, technical expertise and funding support- Initiative focuses on Odisha, the state with the highest burden of malaria in India